Mebendazole Blocks a Cancer-Fueling Import Gate in Cells, Structure Study Shows
Cryo-EM structures of the OCTN1 transporter plus virtual screening identified mebendazole as a potent OCTN1 inhibitor; it suppressed proliferation of cervical and lung cancer cells in vitro. Preclinical — cells only, no animal or patient data yet.
By Sanare Lab · October 16, 2026 · 2 min read
Key Takeaway
Scientists mapped a cellular "import gate" called OCTN1 atom by atom, then used the map to find drugs that jam it — and the anti-parasite pill mebendazole turned out to block it strongly. In lab dishes, mebendazole slowed the growth of cervical and lung cancer cells.
Every cell has transporters — gates in its outer membrane that import nutrients. One of them, OCTN1, imports ergothioneine (an antioxidant made by fungi that our cells hoard) and can also carry acetylcholine, a signaling chemical that — outside the nervous system — helps tumors grow and invade. Overactive OCTN1 has been linked to cancer progression.
The team solved cryo-EM structures of human OCTN1 — cryo-EM is a technique that photographs frozen proteins down to near-atomic detail — showing exactly where ergothioneine binds and how the gate moves as it works. Using that map, they ran a virtual screen (computer testing of drug structures against the binding site) and identified mebendazole, a cheap decades-old deworming drug, as a potent OCTN1 blocker. In cell cultures, mebendazole suppressed the proliferation — the division and multiplication — of cervical and lung cancer cells.
The catch: this was done in dishes, not in animals or patients, and the abstract gives no potency numbers. Blocking a transporter in a dish does not mean the drug will reach tumors in the body at useful doses. For the bigger picture, see our review of 22 mebendazole brain-tumor studies and why mebendazole interests cancer researchers; dosing questions: our dosing calculator.
In plain words
What happened: Researchers took atom-level pictures of a cell's import gate and then searched for medicines that fit its lock. Mebendazole, a common deworming pill, fit — and slowed cervical and lung cancer cells growing in dishes.
Why it matters: This gate can feed tumors a growth signal. If a cheap, well-known pill can jam it, doctors might one day have a new tool — that is why the finding matters.
How strong is the evidence: Very early: protein structures plus cancer cells in lab dishes. No animals, no patients, and no potency numbers were reported in the summary — promising, not proven.
What it means for you: Nothing changes for treatment today. Do not self-medicate with mebendazole — it is a prescription drug. If you have cancer, ask your oncologist about clinical trials.
References
- Structural and mechanistic insights into OCTN1-mediated transport and cancer cell proliferation (preclinical — protein structures and cell cultures, not yet tested in animals or patients). Nature Communications. 2026 Sep 14. doi:10.1038/s41467-026-77727-2. PMID: 42875455.
Medical Disclaimer
This article is informational, not medical advice. Research in cells cannot predict effects in people. Never change medication without consulting your doctor.
Sanare Lab
Science-based health education team reviewing published research on repurposed drugs, integrative oncology, and evidence-based protocols.